Aurora Cannabis (ACB) Total Non-Current Liabilities (2018 - 2025)

Aurora Cannabis (ACB) posted quarterly Total Non-Current Liabilities of $44.1 million for Q4 2025, down 57.7% year-on-year from $104.3 million in Q4 2024, and down 7.5% on a QoQ basis from $47.7 million in Q3 2025.

Aurora Cannabis (ACB) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Total Non-Current Liabilities for 8 consecutive years, with $44.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 57.7% year-over-year to $44.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.1 million (down 57.7% YoY) and the FY2025 annual result came in at $95.8 million, down 14.58% from the prior year.
  • Total Non-Current Liabilities fell to $44.1 million in Q4 2025 per ACB's latest filing, from $47.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for ACB reached as high as $438.0 million in Q3 2022 and fell as low as -$4.2 million in Q2 2022.
  • A 5-year average of $194.8 million and a median of $151.5 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slumped 185.49% — and 2023, when it jumped 3688.19%.
  • Year by year, Total Non-Current Liabilities stood at $419.1 million in 2021, then retreated by 25.22% to $313.4 million in 2022, then slumped by 51.62% to $151.6 million in 2023, then tumbled by 31.19% to $104.3 million in 2024, then plunged by 57.7% to $44.1 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $44.1 million, $47.7 million, and $66.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 44.12 Mn
Sep 30, 2025 47.70 Mn
Jun 30, 2025 66.59 Mn
Mar 31, 2025 92.84 Mn
Dec 31, 2024 104.32 Mn
Sep 30, 2024 116.71 Mn
Jun 30, 2024 119.54 Mn
Mar 31, 2024 171.57 Mn
Dec 31, 2023 151.60 Mn
Sep 30, 2023 151.35 Mn
Jun 30, 2023 152.26 Mn
Mar 31, 2023 296.00 Mn
Dec 31, 2022 313.37 Mn
Sep 30, 2022 438.02 Mn
Jun 30, 2022 -4.24 Mn
Mar 31, 2022 378.58 Mn
Dec 31, 2021 419.08 Mn
Sep 30, 2021 422.99 Mn
Jun 30, 2021 -1.49 Mn
Mar 31, 2021 415.25 Mn